BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28741480)

  • 1. Cadherins Glycans in Cancer: Sweet Players in a Bitter Process.
    Carvalho S; Reis CA; Pinho SS
    Trends Cancer; 2016 Sep; 2(9):519-531. PubMed ID: 28741480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional roles of fucosylated and O-glycosylated cadherins during carcinogenesis and metastasis.
    Ma M; Fu Y; Zhou X; Guan F; Wang Y; Li X
    Cell Signal; 2019 Nov; 63():109365. PubMed ID: 31352008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Cadherins in Cancer-A Review.
    Kaszak I; Witkowska-Piłaszewicz O; Niewiadomska Z; Dworecka-Kaszak B; Ngosa Toka F; Jurka P
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycosylation in cancer: Selected roles in tumour progression, immune modulation and metastasis.
    Rodrigues JG; Balmaña M; Macedo JA; Poças J; Fernandes Â; de-Freitas-Junior JCM; Pinho SS; Gomes J; Magalhães A; Gomes C; Mereiter S; Reis CA
    Cell Immunol; 2018 Nov; 333():46-57. PubMed ID: 29576316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominant Expression of Hybrid N-Glycans Has Distinct Cellular Roles Relative to Complex and Oligomannose N-Glycans.
    Hall MK; Weidner DA; Zhu Y; Dayal S; Whitman AA; Schwalbe RA
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27304954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-glycosylation affects the adhesive function of E-Cadherin through modifying the composition of adherens junctions (AJs) in human breast carcinoma cell line MDA-MB-435.
    Zhao H; Liang Y; Xu Z; Wang L; Zhou F; Li Z; Jin J; Yang Y; Fang Z; Hu Y; Zhang L; Su J; Zha X
    J Cell Biochem; 2008 May; 104(1):162-75. PubMed ID: 17979184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
    de Freitas Junior JC; Morgado-Díaz JA
    Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin.
    de-Freitas-Junior JC; Carvalho S; Dias AM; Oliveira P; Cabral J; Seruca R; Oliveira C; Morgado-Díaz JA; Reis CA; Pinho SS
    PLoS One; 2013; 8(11):e81579. PubMed ID: 24282611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion.
    Lommel M; Winterhalter PR; Willer T; Dahlhoff M; Schneider MR; Bartels MF; Renner-Müller I; Ruppert T; Wolf E; Strahl S
    Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21024-9. PubMed ID: 24297939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-mannosylation and N-glycosylation: two coordinated mechanisms regulating the tumour suppressor functions of E-cadherin in cancer.
    Carvalho S; Oliveira T; Bartels MF; Miyoshi E; Pierce M; Taniguchi N; Carneiro F; Seruca R; Reis CA; Strahl S; Pinho SS
    Oncotarget; 2016 Oct; 7(40):65231-65246. PubMed ID: 27533452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation: a hallmark of cancer?
    Vajaria BN; Patel PS
    Glycoconj J; 2017 Apr; 34(2):147-156. PubMed ID: 27975160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
    Taniguchi N; Kizuka Y
    Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
    Mereiter S; Balmaña M; Campos D; Gomes J; Reis CA
    Cancer Cell; 2019 Jul; 36(1):6-16. PubMed ID: 31287993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of homotypic cell-cell adhesion by branched N-glycosylation of N-cadherin extracellular EC2 and EC3 domains.
    Guo HB; Johnson H; Randolph M; Pierce M
    J Biol Chem; 2009 Dec; 284(50):34986-97. PubMed ID: 19846557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell N-glycans in metastasis.
    Laidler P; Lityńska A
    Acta Biochim Pol; 1997; 44(2):343-57. PubMed ID: 9360725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer.
    Carvalho S; Catarino TA; Dias AM; Kato M; Almeida A; Hessling B; Figueiredo J; Gärtner F; Sanches JM; Ruppert T; Miyoshi E; Pierce M; Carneiro F; Kolarich D; Seruca R; Yamaguchi Y; Taniguchi N; Reis CA; Pinho SS
    Oncogene; 2016 Mar; 35(13):1619-31. PubMed ID: 26189796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer.
    Cornelissen LA; Van Vliet SJ
    Biomolecules; 2016 May; 6(2):. PubMed ID: 27153100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface glycan-lectin interactions in tumor metastasis.
    Rambaruth ND; Dwek MV
    Acta Histochem; 2011 Oct; 113(6):591-600. PubMed ID: 21501858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadherins and epithelial-to-mesenchymal transition.
    Gheldof A; Berx G
    Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of E-cadherin function and dysfunction by N-glycosylation.
    Pinho SS; Seruca R; Gärtner F; Yamaguchi Y; Gu J; Taniguchi N; Reis CA
    Cell Mol Life Sci; 2011 Mar; 68(6):1011-20. PubMed ID: 21104290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.